Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exact Sciences Cor
(NQ:
EXAS
)
69.80
+0.87 (+1.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Exact Sciences Cor
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Will EXACT SCIENCES CORP breakout?
October 30, 2024
With a solid technical rating of 8 out of 10, EXACT SCIENCES CORP (NASDAQ:EXAS) is showing strong indications of a possible breakout.
Via
Chartmill
Deep Dive Into Exact Sciences Stock: Analyst Perspectives (7 Ratings)
October 29, 2024
Via
Benzinga
Can This Beaten-Down Cathie Wood Stock Bounce Back?
October 17, 2024
An updated version of Exact Sciences' key product just got regulatory approval. That could help the healthcare stock stage a comeback.
Via
The Motley Fool
(EXAS) - Analyzing Exact Sciences's Short Interest
October 09, 2024
Via
Benzinga
FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test
October 04, 2024
Exact Sciences' Cologuard Plus test, now FDA-approved, offers a non-invasive screening option for adults 45+ at average risk for colorectal cancer. The test outperformed fecal immunochemical tests in...
Via
Benzinga
Exposures
Product Safety
Exact Sciences Stock Rises After FDA Signs Off On New Cologuard
October 04, 2024
The company is soon to launch its next-generation colon cancer screening tool.
Via
Investor's Business Daily
Exposures
Product Safety
Analyst Ratings For Exact Sciences
October 01, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Exact Sciences
September 12, 2024
Via
Benzinga
Exact Sciences Analysts Slash Their Forecasts After Q2 Results
August 01, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 18, 2024
Via
Benzinga
Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
September 15, 2024
These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also raised price targets for Applovin and Arm Holdings.
Via
Benzinga
Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday
September 12, 2024
Via
Benzinga
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
August 23, 2024
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
Via
News Direct
Exposures
COVID-19
Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights
July 17, 2024
Via
Benzinga
Expert Outlook: Exact Sciences Through The Eyes Of 5 Analysts
June 26, 2024
Via
Benzinga
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Via
Benzinga
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
August 04, 2024
Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H....
Via
Benzinga
Crude Oil Moves Lower; Moderna Shares Plunge
August 01, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July
August 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday
August 01, 2024
Via
Benzinga
Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly Beat
August 01, 2024
The company expects stronger second-half sales vs. the first half of 2024.
Via
Investor's Business Daily
Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript
August 01, 2024
EXAS earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Exact Sciences Stock Climbs After Strong Q2 Results
July 31, 2024
Exact Sciences shares are trading higher after the company reported its second-quarter financial results Wednesday. Here's a look at the details from the report:
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
July 31, 2024
The strugglingh stock investor did a little bit of shopping on Tuesday, adding to some of her existing positions.
Via
The Motley Fool
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
July 29, 2024
FDA approves Guardant Health's Shield blood test for colorectal cancer screening in adults 45+, marking the first FDA-approved blood test as a primary CRC screening option. Shield meets Medicare...
Via
Benzinga
Exposures
Product Safety
Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns
July 22, 2024
The investment banking firm says these companies are among the best stocks to buy and have some strong tailwinds behind them.
Via
InvestorPlace
This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street
July 08, 2024
Investors shouldn't rush to buy the stock based on rosy short-term price targets.
Via
The Motley Fool
The 3 Best Personalized Medicine Stocks to Buy in July 2024
July 03, 2024
Explore promising personalized medicine stocks poised for growth as the industry expands, driven by advancements in genomic technologies.
Via
InvestorPlace
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
June 26, 2024
Via
Benzinga
Mainz Biomed’s ColoAlert Potentially Puts It On A Similar Track As Big Name Cancer Screening Stocks
June 21, 2024
Mainz Biomed’s ColoAlert Potentially Puts It On A Similar Track As Big Name Cancer Screening Stocks
Via
News Direct
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.